Reach Us +1-218-451-2974


Magnetic Resonance Imaging (MRI) in Parkinsons Disease | OMICS International | Abstract
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Magnetic Resonance Imaging (MRI) in Parkinsons Disease

Paul J Tuite1*, Silvia Mangia2 and Shalom Michaeli2

1Department of Neurology, University of Minnesota, Minneapolis, MN, USA

2Department of Radiology, Center for Magnetic Resonance Research (CMRR), University of Minnesota, Minneapolis, MN, 55455 USA

Corresponding Author:
Paul J Tuite, MD
Associate Professor, Director of Movement Disorders
Department of Neurology, MMC 295 420 Delaware ST SE
Minneapolis, MN, 55455 USA
Tel: 612-625-9662
E-mail: [email protected]

Received date: February 14, 2013; Accepted date: March 15, 2013; Published date: March 25, 2013

Citation: Tuite PJ, Mangia S, Michaeli S (2013) Magnetic Resonance Imaging (MRI) in Parkinson’s Disease. J Alzheimers Dis S1:001. doi:10.4172/2161-0460.S1-001

Copyright: © 2013 Tuite PJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Recent developments in brain imaging methods are on the verge of changing the evaluation of people with Parkinson’s disease (PD). This includes an assortment of techniques ranging from diffusion tensor imaging (DTI) to iron-sensitive methods such as T2 *, as well as adiabatic methods R1ρ and R2ρ, resting-state functional MRI, and magnetic resonance spectroscopy (MRS). Using a multi-modality approach that ascertains different aspects of the pathophysiology or pathology of PD, it may be possible to better characterize disease phenotypes as well as provide a surrogate of disease and a potential means to track disease progression.